TP53 and ovarian cancer: However, our recent study shed new light on this intriguing phenomenon, revealing that a stable knockdown of CRNDE in ovarian cancer cells harboring a homozygous null TP53 mutation (SK-OV-3) resulted in massive up-regulation of hundreds of genes, and their number was significantly higher than those which were down-regulated [5].